PDCD1 and cancer: We have also in multiple tumor models observed that Nano-DOX upregulates PD-L1 in cancer cells and PD-1 in tumor associated immune cells and Nano-DOX has synergistic interactions with PD-L1/PD-1 inhibitors (unpublished data).